- Federal agenciesExpands federal funding for plant and microbial biology, enabling more basic and translational research projects.
- Targeted stakeholdersIncreases development of research tools and infrastructure that accelerate agricultural biotechnology innovations.
- WorkersBoosts collaborations between universities, industry, and government through consortia-funded projects.
NSF Plant Biology Act
Referred to the House Committee on Science, Space, and Technology.
This bill adds a new section to the NSF Authorization Act creating competitive, merit-reviewed grants for plant and microbial biology research relevant to agriculture, food, or biotechnology.
Eligible recipients include universities, nonprofit organizations, private entities, and federal, state, local, or Tribal governments or consortia.
It authorizes $150 million per year for FY2026–2031 and amends the NSF Act's definitions to clarify nonprofit eligibility under IRC section 501(c)(3).
Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.
Relative to its intended legislative type, this bill establishes a clear statutory authorization and funding stream for NSF grants supporting plant and microbial biology research and incorporates minimal statutory integration (a definition amendment). It provides basic authority and appropriations but limited operational, oversight, and risk-mitigation detail.
Whether funding primarily serves public good or private firms
Who stands to gain, and who may push back.
- Federal agenciesAdds $150 million annually, increasing federal discretionary spending and budgetary obligations.
- Federal agenciesCould overlap or duplicate existing USDA, DOE, or NSF plant biology programs, diluting federal coordination.
- Targeted stakeholdersMay privilege biotechnology commercialization, potentially shifting emphasis away from noncommercial basic research.
Why the argument around this bill splits.
Whether funding primarily serves public good or private firms
Generally supportive because it expands public funding for basic plant and microbial science with clear links to food security and biotechnology.
Concerned about ensuring public-interest safeguards around access, environmental impacts, and equitable benefit sharing.
Cautiously favorable as a targeted federal investment in science and agricultural competitiveness, but wants clearer accountability, interagency coordination, and cost oversight.
Sees merit review and competitive grants as appropriate delivery mechanisms.
Skeptical overall: supports basic science that boosts agriculture but worries about expanding NSF's role, recurring federal spending, and taxpayer-funded research that may advantage large private firms.
Seeks tighter limits and stronger oversight.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.
- Whether appropriators will fund the authorized $150M annually
- Potential overlap with USDA or existing NSF programs
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether funding primarily serves public good or private firms
Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.
Relative to its intended legislative type, this bill establishes a clear statutory authorization and funding stream for NSF grants supporting plant and microbial biology research and incorporates minimal statutory integ…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.